You are here: Home: BCU 1|2002: Robert W Carlson, MD

EVOLUTION OF THE NCCN BREAST CANCER GUIDELINE

The breast cancer guidelines panel has expanded from six members to 20 or more panel members. The guidelines started as quite broad and relatively simple algorithms to allow flexibility among the practitioners. Although we have maintained broad treatment options within the guidelines, we have become much more detailed and specific over the years.

I find it quite fascinating that each year new evidence forces us to really change the guideline; and the breast panel of the NCCN is the only one whose guidelines undergo annual revision. This tells us something about the quality and quantity of ongoing international research in breast cancer. It has truly been a joy getting to know and working with the other panel members, a superb group of clinicians and scientists. It’s also very gratifying to see the American Cancer Society and the NCCN modify the guidelines for a lay audience. Patients come into my office with the guidelines that I have — in part — been involved in developing, to talk with me about how they should be treated. That makes my job easier.

NCCN BREAST CANCER PANEL MEMBERS

Robert W Carlson, MD/Chair
Stanford Hospital and Clinics

Benjamin O Anderson, MD
University of Washington
Medical Center

William Bensinger, MD
Fred Hutchinson Cancer
Research Center

Charles E Cox, MD
H. Lee Moffitt
Cancer Center

Stephen B Edge, MD
Roswell Park Cancer Institute

William B Farrar, MD
Arthur G James Cancer Hospital &
Richard J. Solove
Research Institute at
Ohio State University

Lori J Goldstein, MD
Fox Chase Cancer Center

William J Gradishar, MD
Robert H Lurie Comprehensive Cancer Center of Northwestern University

Beryl McCormick, MD Memorial Sloan-Kettering Cancer Center

Lisle M Nabell, MD
University of Alabama at
Birmingham Comprehensive
Cancer Center

Lori J Pierce, MD
University of Michigan
Comprehensive Cancer Center

Elizabeth C Reed, MD
UNMC Eppley Cancer Center at
the University of Nebraska Medical Center

Samuel M Silver, MD, PhD
University of Michigan
Comprehensive Cancer Center

Mary Lou Smith
Consultant

George Somlo, MD
City of Hope Cancer Center

Richard Theriault, DO, MBA
University of Texas M. D. Anderson
Cancer Center

John H Ward, MD
Huntsman Cancer Institute at
the University of Utah

Eric P Winer, MD
Dana-Farber Cancer Institute

 

NCCN INTITUTIONS  

• Fred Hutchinson
Cancer Research Center

• UCSF Comprehensive
Cancer Center

• Huntsman Cancer Institute
at the University of Utah

• Stanford University
Medical Center

• City of Hope
Cancer Center

• Robert H Lurie Comprehensive Cancer
Center of Northwestern University

• UNMC Eppley Cancer Center
at the University of Nebraska
Medical Center

• St. Jude Children’s
Research Hospital

• University of Texas
MD Anderson Cancer Center

• University of Michigan
Comprehensive Cancer Center

 

• Arthur G James Cancer
Hospital & Richard J Solove
Research Institute at The Ohio
State University

• University of Alabama
at Birmingham Comprehensive
Cancer Center

• Roswell Park
Cancer Institute

• Dana-Farber
Cancer Institute

• Memorial Sloan-Kettering
Cancer Center

• Fox Chase Cancer Center

• Johns Hopkins Comprehensive
Cancer Center

• Duke Comprehensive
Cancer Center

• H Lee Moffitt Cancer Center
& Research Institute at the
University of South Florida

INFORMATION ABOUT THE NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES

These guidelines are a work in progress that will be refined as often as new significant data becomes available.

The NCCN guidelines are a statement of consensus of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult any NCCN guideline is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient's care or treatment. The National Comprehensive Cancer Network makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

These guidelines are copyrighted by the National Comprehensive Cancer Network. All rights reserved. These guidelines and illustrations herein may not be reproduced in any form for any purpose without the express written permission of the NCCN.

Select References

Page 3 of 3
Previous Page

 

Table of Contents Top of Page

 

 

Home · Search

 
Home · Contact us
Terms of use and general disclaimer